Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Commercial Products
INCY logo

Incyte Net Income Surges to $1.28 Billion Driven by JAKAFI and Novartis Settlement

INCY10-KFiling Date: 2/10/2026
Incyte Corporation
Description

What this story covers

Incyte Corporation reported a massive 2025 net income of $1.28 billion, fueled by strong JAKAFI and OPZELURA sales and a $242 million Novartis settlement. The company is aggressively advancing its pipeline to offset 2028 patent expirations.

Story snapshot

CompanyIncyte Corporation
TickerINCY
VariantStandard detailed
Duration12:49
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0000879169-26-000010
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in